Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 6537 entries
Sorted by: Best Match Show Resources per page
Videovaginoscopy of the canine vagina.

Reproduction in domestic animals = Zuchthygiene

Lévy X.
PMID: 27670938
Reprod Domest Anim. 2016 Sep;51:31-36. doi: 10.1111/rda.12785.

Endoscopy enables a rapid and non-traumatic examination of the vaginal cavity of female dogs. Its implementation requires specific equipment as well as knowledge about the species-specific vaginal anatomy and the procedure. Vaginoscopy is the diagnostic tool of choice for...

Cite
Lévy X. Videovaginoscopy of the canine vagina. Reprod Domest Anim. 2016;51:31-36doi: 10.1111/rda.12785.
Lévy, X. (2016). Videovaginoscopy of the canine vagina. Reproduction in domestic animals = Zuchthygiene, 5131-36. https://doi.org/10.1111/rda.12785
Lévy, X. "Videovaginoscopy of the canine vagina." Reproduction in domestic animals = Zuchthygiene vol. 51 (2016): 31-36. doi: https://doi.org/10.1111/rda.12785
Lévy X. Videovaginoscopy of the canine vagina. Reprod Domest Anim. 2016 Sep;51:31-36. doi: 10.1111/rda.12785. PMID: 27670938.
Copy Download .nbib Format: NLM
A thermosensitive glycol chitin hydrogel for the vaginal delivery of progesterone.

Journal of controlled release : official journal of the Controlled Release Society

Almomen AA, Cho S, Li Z, Huh KM, Matthew Peterson C, Janát-Amsbury MM.
PMID: 27005222
J Control Release. 2015 Sep 10;213:e74-5. doi: 10.1016/j.jconrel.2015.05.123. Epub 2015 Aug 19.

No abstract available.

Cite
Almomen AA, Cho S, Li Z, et al. A thermosensitive glycol chitin hydrogel for the vaginal delivery of progesterone. J Control Release. 2015;213:e74-5doi: 10.1016/j.jconrel.2015.05.123.
Almomen, A. A., Cho, S., Li, Z., Huh, K. M., Matthew Peterson, C., & Janát-Amsbury, M. M. (2015). A thermosensitive glycol chitin hydrogel for the vaginal delivery of progesterone. Journal of controlled release : official journal of the Controlled Release Society, 213e74-5. https://doi.org/10.1016/j.jconrel.2015.05.123
Almomen, Aliyah A, et al. "A thermosensitive glycol chitin hydrogel for the vaginal delivery of progesterone." Journal of controlled release : official journal of the Controlled Release Society vol. 213 (2015): e74-5. doi: https://doi.org/10.1016/j.jconrel.2015.05.123
Almomen AA, Cho S, Li Z, Huh KM, Matthew Peterson C, Janát-Amsbury MM. A thermosensitive glycol chitin hydrogel for the vaginal delivery of progesterone. J Control Release. 2015 Sep 10;213:e74-5. doi: 10.1016/j.jconrel.2015.05.123. Epub 2015 Aug 19. PMID: 27005222.
Copy Download .nbib Format: NLM
Hormonal based treatment of ovarian anaplastic ependymoma with anastrozole.

Gynecologic oncology reports

Gorski JW, Taylor JS, Zhang J, Liu J, Jazaeri AA.
PMID: 28393092
Gynecol Oncol Rep. 2017 Mar 14;20:93-96. doi: 10.1016/j.gore.2017.03.005. eCollection 2017 May.

OBJECTIVE: Ovarian anaplastic ependymoma is a rare gynecologic malignancy that poses diagnostic and treatment challenges. Treatment of sub-optimally debulked disease usually portends poor prognosis. Molecular testing of tumor specimen can identify more specific targets for additional therapy such as...

Cite
Gorski JW, Taylor JS, Zhang J, et al. Hormonal based treatment of ovarian anaplastic ependymoma with anastrozole. Gynecol Oncol Rep. 2017;20:93-96doi: 10.1016/j.gore.2017.03.005.
Gorski, J. W., Taylor, J. S., Zhang, J., Liu, J., & Jazaeri, A. A. (2017). Hormonal based treatment of ovarian anaplastic ependymoma with anastrozole. Gynecologic oncology reports, 2093-96. https://doi.org/10.1016/j.gore.2017.03.005
Gorski, Justin Wayne, et al. "Hormonal based treatment of ovarian anaplastic ependymoma with anastrozole." Gynecologic oncology reports vol. 20 (2017): 93-96. doi: https://doi.org/10.1016/j.gore.2017.03.005
Gorski JW, Taylor JS, Zhang J, Liu J, Jazaeri AA. Hormonal based treatment of ovarian anaplastic ependymoma with anastrozole. Gynecol Oncol Rep. 2017 Mar 14;20:93-96. doi: 10.1016/j.gore.2017.03.005. eCollection 2017 May. PMID: 28393092; PMCID: PMC5376265.
Copy Download .nbib Format: NLM
High excision repair cross-complementation group 1 expression is associated with favorable prognostic factors in breast cancer.

Oncology letters

Kim DH, Lee H, Kim DH, Chae SW, Sohn JH, Kim K, Do SI.
PMID: 28943968
Oncol Lett. 2017 Oct;14(4):4995-5003. doi: 10.3892/ol.2017.6737. Epub 2017 Aug 09.

Distortion of DNA can inhibit transcription and replication, resulting in cell death. The nucleotide excision repair (NER) pathway recognizes and repairs DNA adducts. Excision repair cross-complementation group 1 (ERCC1) is a nuclease that serves a vital role in the...

Cite
Kim DH, Lee H, Kim DH, et al. High excision repair cross-complementation group 1 expression is associated with favorable prognostic factors in breast cancer. Oncol Lett. 2017;14(4):4995-5003doi: 10.3892/ol.2017.6737.
Kim, D. H., Lee, H., Kim, D. H., Chae, S. W., Sohn, J. H., Kim, K., & Do, S. I. (2017). High excision repair cross-complementation group 1 expression is associated with favorable prognostic factors in breast cancer. Oncology letters, 14(4), 4995-5003. https://doi.org/10.3892/ol.2017.6737
Kim, Dong Hyun, et al. "High excision repair cross-complementation group 1 expression is associated with favorable prognostic factors in breast cancer." Oncology letters vol. 14,4 (2017): 4995-5003. doi: https://doi.org/10.3892/ol.2017.6737
Kim DH, Lee H, Kim DH, Chae SW, Sohn JH, Kim K, Do SI. High excision repair cross-complementation group 1 expression is associated with favorable prognostic factors in breast cancer. Oncol Lett. 2017 Oct;14(4):4995-5003. doi: 10.3892/ol.2017.6737. Epub 2017 Aug 09. PMID: 28943968; PMCID: PMC5594248.
Copy Download .nbib Format: NLM
Decreased sirtuin 4 expression is associated with poor prognosis in patients with invasive breast cancer.

Oncology letters

Shi Q, Liu T, Zhang X, Geng J, He X, Nu M, Pang D.
PMID: 27698834
Oncol Lett. 2016 Oct;12(4):2606-2612. doi: 10.3892/ol.2016.5021. Epub 2016 Aug 16.

Aberrant metabolism is a hallmark of human cancer. Glutamine metabolism has been identified as a central metabolic pathway in cancer and thus, targeting glutamine metabolism may exhibit therapeutic potential. Sirtuin 4 (SIRT4) is an important molecule that mediates the...

Cite
Shi Q, Liu T, Zhang X, et al. Decreased sirtuin 4 expression is associated with poor prognosis in patients with invasive breast cancer. Oncol Lett. 2016;12(4):2606-2612doi: 10.3892/ol.2016.5021.
Shi, Q., Liu, T., Zhang, X., Geng, J., He, X., Nu, M., & Pang, D. (2016). Decreased sirtuin 4 expression is associated with poor prognosis in patients with invasive breast cancer. Oncology letters, 12(4), 2606-2612. https://doi.org/10.3892/ol.2016.5021
Shi, Qingyu, et al. "Decreased sirtuin 4 expression is associated with poor prognosis in patients with invasive breast cancer." Oncology letters vol. 12,4 (2016): 2606-2612. doi: https://doi.org/10.3892/ol.2016.5021
Shi Q, Liu T, Zhang X, Geng J, He X, Nu M, Pang D. Decreased sirtuin 4 expression is associated with poor prognosis in patients with invasive breast cancer. Oncol Lett. 2016 Oct;12(4):2606-2612. doi: 10.3892/ol.2016.5021. Epub 2016 Aug 16. PMID: 27698834; PMCID: PMC5038587.
Copy Download .nbib Format: NLM
Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.

The journal of pathology. Clinical research

Howat WJ, Blows FM, Provenzano E, Brook MN, Morris L, Gazinska P, Johnson N, McDuffus LA, Miller J, Sawyer EJ, Pinder S, van Deurzen CH, Jones L, Sironen R, Visscher D, Caldas C, Daley F, Coulson P, Broeks A, Sanders J, Wesseling J, Nevanlinna H, Fagerholm R, Blomqvist C, Heikkilä P, Ali HR, Dawson SJ, Figueroa J, Lissowska J, Brinton L, Mannermaa A, Kataja V, Kosma VM, Cox A, Brock IW, Cross SS, Reed MW, Couch FJ, Olson JE, Devillee P, Mesker WE, Seyaneve CM, Hollestelle A, Benitez J, Perez JI, Menéndez P, Bolla MK, Easton DF, Schmidt MK, Pharoah PD, Sherman ME, García-Closas M.
PMID: 27499890
J Pathol Clin Res. 2014 Dec 04;1(1):18-32. doi: 10.1002/cjp2.3. eCollection 2015 Jan.

Breast cancer risk factors and clinical outcomes vary by tumour marker expression. However, individual studies often lack the power required to assess these relationships, and large-scale analyses are limited by the need for high throughput, standardized scoring methods. To...

Cite
Howat WJ, Blows FM, Provenzano E, et al. Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium. J Pathol Clin Res. 2014;1(1):18-32doi: 10.1002/cjp2.3.
Howat, W. J., Blows, F. M., Provenzano, E., Brook, M. N., Morris, L., Gazinska, P., Johnson, N., McDuffus, L. A., Miller, J., Sawyer, E. J., Pinder, S., van Deurzen, C. H., Jones, L., Sironen, R., Visscher, D., Caldas, C., Daley, F., Coulson, P., Broeks, A., Sanders, J., Wesseling, J., Nevanlinna, H., Fagerholm, R., Blomqvist, C., Heikkilä, P., Ali, H. R., Dawson, S. J., Figueroa, J., Lissowska, J., Brinton, L., Mannermaa, A., Kataja, V., Kosma, V. M., Cox, A., Brock, I. W., Cross, S. S., Reed, M. W., Couch, F. J., Olson, J. E., Devillee, P., Mesker, W. E., Seyaneve, C. M., Hollestelle, A., Benitez, J., Perez, J. I., Menéndez, P., Bolla, M. K., Easton, D. F., Schmidt, M. K., Pharoah, P. D., Sherman, M. E., & García-Closas, M. (2015). Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium. The journal of pathology. Clinical research, 1(1), 18-32. https://doi.org/10.1002/cjp2.3
Howat, William J, et al. "Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium." The journal of pathology. Clinical research vol. 1,1 (2015): 18-32. doi: https://doi.org/10.1002/cjp2.3
Howat WJ, Blows FM, Provenzano E, Brook MN, Morris L, Gazinska P, Johnson N, McDuffus LA, Miller J, Sawyer EJ, Pinder S, van Deurzen CH, Jones L, Sironen R, Visscher D, Caldas C, Daley F, Coulson P, Broeks A, Sanders J, Wesseling J, Nevanlinna H, Fagerholm R, Blomqvist C, Heikkilä P, Ali HR, Dawson SJ, Figueroa J, Lissowska J, Brinton L, Mannermaa A, Kataja V, Kosma VM, Cox A, Brock IW, Cross SS, Reed MW, Couch FJ, Olson JE, Devillee P, Mesker WE, Seyaneve CM, Hollestelle A, Benitez J, Perez JI, Menéndez P, Bolla MK, Easton DF, Schmidt MK, Pharoah PD, Sherman ME, García-Closas M. Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium. J Pathol Clin Res. 2014 Dec 04;1(1):18-32. doi: 10.1002/cjp2.3. eCollection 2015 Jan. PMID: 27499890; PMCID: PMC4858117.
Copy Download .nbib Format: NLM
Steroid hormone receptors as prognostic markers in breast cancer.

American journal of cancer research

Louie MC, Sevigny MB.
PMID: 28861319
Am J Cancer Res. 2017 Aug 01;7(8):1617-1636. eCollection 2017.

Despite the existence of many promising anti-cancer therapies, not all breast cancers are equally treatable, due partly to the fact that focus has been primarily on a few select breast cancer biomarkers- notably ERα, PR and HER2. In cases...

Cite
Louie MC, Sevigny MB. Steroid hormone receptors as prognostic markers in breast cancer. Am J Cancer Res. 2017;7(8):1617-1636
Louie, M. C., & Sevigny, M. B. (2017). Steroid hormone receptors as prognostic markers in breast cancer. American journal of cancer research, 7(8), 1617-1636.
Louie, Maggie C, and Sevigny, Mary B. "Steroid hormone receptors as prognostic markers in breast cancer." American journal of cancer research vol. 7,8 (2017): 1617-1636.
Louie MC, Sevigny MB. Steroid hormone receptors as prognostic markers in breast cancer. Am J Cancer Res. 2017 Aug 01;7(8):1617-1636. eCollection 2017. PMID: 28861319; PMCID: PMC5574935.
Copy Download .nbib Format: NLM
Uterine involution and progesterone level during the postpartum period in Barbary ewes in north Libya.

Open veterinary journal

Medan MS, El-Daek T.
PMID: 26623357
Open Vet J. 2015;5(1):18-22. Epub 2015 Feb 18.

The objectives of the present study were to determine the time of uterine involution and ovarian activity using ultrasound examination and progesterone assay. Weekly progesterone levels were measured starting one week postpartum until two weeks after the 1(st) postpartum...

Cite
Medan MS, El-Daek T. Uterine involution and progesterone level during the postpartum period in Barbary ewes in north Libya. Open Vet J. 2015;5(1):18-22
Medan, M. S., & El-Daek, T. (2015). Uterine involution and progesterone level during the postpartum period in Barbary ewes in north Libya. Open veterinary journal, 5(1), 18-22.
Medan, M S, and El-Daek, T. "Uterine involution and progesterone level during the postpartum period in Barbary ewes in north Libya." Open veterinary journal vol. 5,1 (2015): 18-22.
Medan MS, El-Daek T. Uterine involution and progesterone level during the postpartum period in Barbary ewes in north Libya. Open Vet J. 2015;5(1):18-22. Epub 2015 Feb 18. PMID: 26623357; PMCID: PMC4629562.
Copy Download .nbib Format: NLM
Endometriosis: alternative methods of medical treatment.

International journal of women's health

Muñoz-Hernando L, Muñoz-Gonzalez JL, Marqueta-Marques L, Alvarez-Conejo C, Tejerizo-García Á, Lopez-Gonzalez G, Villegas-Muñoz E, Martin-Jimenez A, Jiménez-López JS.
PMID: 26089705
Int J Womens Health. 2015 Jun 11;7:595-603. doi: 10.2147/IJWH.S78829. eCollection 2015.

Endometriosis is an inflammatory estrogen-dependent disease defined by the presence of endometrial glands and stroma at extrauterine sites. The main purpose of endometriosis management is alleviating pain associated to the disease. This can be achieved surgically or medically, although...

Cite
Muñoz-Hernando L, Muñoz-Gonzalez JL, Marqueta-Marques L, et al. Endometriosis: alternative methods of medical treatment. Int J Womens Health. 2015;7:595-603doi: 10.2147/IJWH.S78829.
Muñoz-Hernando, L., Muñoz-Gonzalez, J. L., Marqueta-Marques, L., Alvarez-Conejo, C., Tejerizo-García, �. �., Lopez-Gonzalez, G., Villegas-Muñoz, E., Martin-Jimenez, A., & Jiménez-López, J. S. (2015). Endometriosis: alternative methods of medical treatment. International journal of women's health, 7595-603. https://doi.org/10.2147/IJWH.S78829
Muñoz-Hernando, Leticia, et al. "Endometriosis: alternative methods of medical treatment." International journal of women's health vol. 7 (2015): 595-603. doi: https://doi.org/10.2147/IJWH.S78829
Muñoz-Hernando L, Muñoz-Gonzalez JL, Marqueta-Marques L, Alvarez-Conejo C, Tejerizo-García Á, Lopez-Gonzalez G, Villegas-Muñoz E, Martin-Jimenez A, Jiménez-López JS. Endometriosis: alternative methods of medical treatment. Int J Womens Health. 2015 Jun 11;7:595-603. doi: 10.2147/IJWH.S78829. eCollection 2015. PMID: 26089705; PMCID: PMC4468987.
Copy Download .nbib Format: NLM
Analysis of the clinical and molecular characteristics of a child with achondroplasia: A case report.

Experimental and therapeutic medicine

Liu J, Tang X, Cheng J, Wang L, Yang X, Wang Y.
PMID: 26136890
Exp Ther Med. 2015 May;9(5):1763-1767. doi: 10.3892/etm.2015.2324. Epub 2015 Mar 02.

Achondroplasia (ACH) is a hereditary dwarfism caused by the disturbed proliferation and differentiation of growth plate chondrocytes, followed by impaired endochondral bone growth. ACH is caused by mutations in the gene encoding the transmembrane receptor, fibroblast growth factor receptor...

Cite
Liu J, Tang X, Cheng J, et al. Analysis of the clinical and molecular characteristics of a child with achondroplasia: A case report. Exp Ther Med. 2015;9(5):1763-1767doi: 10.3892/etm.2015.2324.
Liu, J., Tang, X., Cheng, J., Wang, L., Yang, X., & Wang, Y. (2015). Analysis of the clinical and molecular characteristics of a child with achondroplasia: A case report. Experimental and therapeutic medicine, 9(5), 1763-1767. https://doi.org/10.3892/etm.2015.2324
Liu, Jingfang, et al. "Analysis of the clinical and molecular characteristics of a child with achondroplasia: A case report." Experimental and therapeutic medicine vol. 9,5 (2015): 1763-1767. doi: https://doi.org/10.3892/etm.2015.2324
Liu J, Tang X, Cheng J, Wang L, Yang X, Wang Y. Analysis of the clinical and molecular characteristics of a child with achondroplasia: A case report. Exp Ther Med. 2015 May;9(5):1763-1767. doi: 10.3892/etm.2015.2324. Epub 2015 Mar 02. PMID: 26136890; PMCID: PMC4471706.
Copy Download .nbib Format: NLM
MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases.

Molecular and clinical oncology

Mundim FG, Pasini FS, Brentani MM, Soares FA, Nonogaki S, Waitzberg AF.
PMID: 26137258
Mol Clin Oncol. 2015 May;3(3):506-514. doi: 10.3892/mco.2015.526. Epub 2015 Mar 06.

The MYC oncogene is directly involved in the proliferation, metabolism, progression and distant metastasis of breast cancer. Since metastatic spread to the lymph nodes is often the first indication of propensity for metastatic dissemination, the MYC status in nodal...

Cite
Mundim FG, Pasini FS, Brentani MM, et al. MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases. Mol Clin Oncol. 2015;3(3):506-514doi: 10.3892/mco.2015.526.
Mundim, F. G., Pasini, F. S., Brentani, M. M., Soares, F. A., Nonogaki, S., & Waitzberg, A. F. (2015). MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases. Molecular and clinical oncology, 3(3), 506-514. https://doi.org/10.3892/mco.2015.526
Mundim, Fiorita Gonzales Lopes, et al. "MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases." Molecular and clinical oncology vol. 3,3 (2015): 506-514. doi: https://doi.org/10.3892/mco.2015.526
Mundim FG, Pasini FS, Brentani MM, Soares FA, Nonogaki S, Waitzberg AF. MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases. Mol Clin Oncol. 2015 May;3(3):506-514. doi: 10.3892/mco.2015.526. Epub 2015 Mar 06. PMID: 26137258; PMCID: PMC4471527.
Copy Download .nbib Format: NLM
Expression data from primary culture human myometrial cells.

Genomics data

Lei K, Sooranna SR, Johnson MR.
PMID: 26697367
Genom Data. 2015 Sep 12;6:182-3. doi: 10.1016/j.gdata.2015.09.008. eCollection 2015 Dec.

Inflammation plays a central role in many human diseases. Human parturition also resembles an inflammatory reaction, where progesterone (P4) and progesterone receptors (PRs) have already been demonstrated to suppress contraction-associated gene expression. In our previous studies, we have found...

Cite
Lei K, Sooranna SR, Johnson MR. Expression data from primary culture human myometrial cells. Genom Data. 2015;6:182-3doi: 10.1016/j.gdata.2015.09.008.
Lei, K., Sooranna, S. R., & Johnson, M. R. (2015). Expression data from primary culture human myometrial cells. Genomics data, 6182-3. https://doi.org/10.1016/j.gdata.2015.09.008
Lei, Kaiyu, et al. "Expression data from primary culture human myometrial cells." Genomics data vol. 6 (2015): 182-3. doi: https://doi.org/10.1016/j.gdata.2015.09.008
Lei K, Sooranna SR, Johnson MR. Expression data from primary culture human myometrial cells. Genom Data. 2015 Sep 12;6:182-3. doi: 10.1016/j.gdata.2015.09.008. eCollection 2015 Dec. PMID: 26697367; PMCID: PMC4664736.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 6537 entries